Brief: Theravance Announces Publication of YUPELRI® (revefenacin) Area
18/10/2024 14:20
Oct 18 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE ANNOUNCES PUBLICATION OF YUPELRI® (REVEFENACIN)
AREA
UNDER THE CURVE SPIROMETRY ANALYSIS IN THE INTERNATIONAL JOURNAL
OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source text for Eikon: ID:nPn33vMdLa
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy